Largest Drug Manufacturers - General Companies by Market Cap
The Drug Manufacturers - General sector has 87 publicly listed stocks with a combined market cap of $7.11 Trillion. Eli Lilly and Company leads the sector with a market cap of $936.50 Billion. This ranking covers all Drug Manufacturers - General stocks globally — from large-cap industry leaders to mid-cap and small-cap companies — ranked by market capitalization and updated daily.
Total Market Cap (USD)
$7.11 Trillion
Companies Listed
87
Largest Company
Eli Lilly and …
| Rank | Company | Market Cap (USD) | Market Cap (Local) | Country | Price | 24h Change | 7d Change | 24h Volume |
|---|---|---|---|---|---|---|---|---|
| 1 |
Eli Lilly and Company
NYSE:LLY |
$936.50 Billion | $936.50 Billion | USA | $1098.57 | -1.21% | -3.33% | 71.64 Million |
| 2 |
Eli Lilly and Company
SA:LILY34 |
$853.51 Billion | R$4.35 Trillion | Brazil | R$153.70 | +0.70% | -0.16% | 250.45K |
| 3 |
Johnson & Johnson
NYSE:JNJ |
$550.26 Billion | $550.26 Billion | USA | $228.39 | -2.48% | -4.23% | 180.14 Million |
| 4 |
AbbVie Inc
NYSE:ABBV |
$356.49 Billion | $356.49 Billion | USA | $216.49 | -2.14% | -3.76% | 116.26 Million |
| 5 |
AstraZeneca PLC
MX:AZNN |
$290.50 Billion | MX$5.05 Trillion | Mexico | MX$1628.00 | +1.25% | -4.81% | 6.50K |
| 6 |
AstraZeneca PLC
NASDAQ:AZN |
$282.04 Billion | $282.04 Billion | USA | $187.03 | -1.43% | +1.12% | 43.91 Million |
| 7 |
Novartis AG
MX:NVSN |
$281.45 Billion | MX$4.89 Trillion | Mexico | MX$2563.00 | -1.46% | -0.08% | 14.16K |
| 8 |
Novartis AG ADR
NYSE:NVS |
$281.41 Billion | $281.41 Billion | USA | $147.48 | +0.11% | -3.02% | 34.68 Million |
| 9 |
Merck & Company Inc
NYSE:MRK |
$281.24 Billion | $281.24 Billion | USA | $113.87 | -1.36% | -4.38% | 276.37 Million |
| 10 |
AstraZeneca PLC
NYSE:AZN |
$271.29 Billion | $271.29 Billion | USA | $174.93 | -1.66% | -2.25% | 45.07 Million |
| 11 |
Roche Holding AG
SW:ROG |
$256.43 Billion | CHF202.83 Billion | Switzerland | CHF320.70 | +0.79% | -8.76% | 28.40 Million |
| 12 |
AstraZeneca PLC
F:ZEGA |
$252.57 Billion | €216.04 Billion | Germany | €75.50 | -3.82% | -2.58% | 3.45K |
| 13 |
Roche Holding AG
SW:ROP |
$250.86 Billion | CHF198.42 Billion | Switzerland | CHF319.80 | +0.25% | -1.69% | 28.77 Million |
| 14 |
Novartis AG
SW:NOVN |
$216.30 Billion | CHF171.09 Billion | Switzerland | CHF118.78 | +0.63% | -2.27% | 73.88 Million |
| 15 |
Amgen Inc
NASDAQ:AMGN |
$181.97 Billion | $181.97 Billion | USA | $337.60 | -1.19% | -0.04% | 70.47 Million |
| 16 |
Novo Nordisk A/S
CO:NOVO-B |
$154.55 Billion | Dkr987.78 Billion | Denmark | Dkr292.95 | +4.59% | +3.68% | 137.19 Million |
| 17 |
Gilead Sciences Inc
NASDAQ:GILD |
$153.55 Billion | $153.55 Billion | USA | $123.76 | -1.35% | +1.88% | 191.68 Million |
| 18 |
Pfizer Inc
SA:PFIZ34 |
$147.67 Billion | R$752.56 Billion | Brazil | R$33.09 | -0.78% | -2.25% | 179.03K |
| 19 |
Pfizer Inc
NYSE:PFE |
$143.68 Billion | $143.68 Billion | USA | $25.21 | -2.74% | -1.52% | 766.26 Million |
| 20 |
GlaxoSmithKline PLC ADR
NYSE:GSK |
$111.15 Billion | $111.15 Billion | USA | $55.63 | -0.13% | -3.77% | 93.36 Million |
| 21 |
Bristol-Myers Squibb Company
NYSE:BMY |
$110.27 Billion | $110.27 Billion | USA | $54.00 | -2.32% | -2.88% | 241.07 Million |
| 22 |
Sanofi
F:SNW2 |
$104.50 Billion | €89.39 Billion | Germany | €36.80 | -0.54% | -2.13% | 0.00 |
| 23 |
Sanofi
MX:SNYN |
$104.14 Billion | MX$1.81 Trillion | Mexico | MX$755.29 | -0.09% | -10.62% | 5.90K |
| 24 |
GlaxoSmithKline plc
MX:GSKN |
$104.06 Billion | MX$1.81 Trillion | Mexico | MX$901.11 | -0.98% | +0.09% | 3.52K |
| 25 |
GSK PLC SP. ADR/2 NEW
F:GS70 |
$101.34 Billion | €86.68 Billion | Germany | €47.20 | +0.00% | -3.28% | 120.00 |
| 26 |
Sanofi SA
PA:SAN |
$95.70 Billion | €81.86 Billion | France | €74.14 | +1.09% | -2.83% | 64.29 Million |
| 27 |
Roche Holding AG
SW:RO |
$43.84 Billion | CHF34.67 Billion | Switzerland | CHF325.00 | +0.25% | -1.75% | 845.32K |
| 28 |
Bayer AG NA
XETRA:BAYN |
$36.43 Billion | €31.16 Billion | Germany | €37.84 | +1.86% | +5.73% | 74.21 Million |
| 29 |
Biogen Inc
NASDAQ:BIIB |
$27.74 Billion | $27.74 Billion | USA | $196.58 | -1.05% | +1.20% | 23.66 Million |
| 30 |
ASTELLAS PHARMA UNSP.ADR
F:YPHA |
$19.55 Billion | €16.72 Billion | Germany | €12.90 | +0.00% | -3.73% | 2.40K |
| 31 |
CSPC PHARMACEUT.GR. ADR4
F:CVGU |
$11.04 Billion | €9.44 Billion | Germany | €3.52 | +0.00% | -6.38% | 45.00 |
| 32 |
CSPC Pharmaceutical Group Limited
F:CVG |
$9.99 Billion | €8.54 Billion | Germany | €0.75 | +1.91% | -2.92% | 0.00 |
| 33 |
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SHG:600436 |
$9.97 Billion | CN¥68.11 Billion | China | CN¥112.89 | -1.49% | -3.92% | 93.76 Million |
| 34 |
Orion Oyj B
HE:ORNBV |
$8.48 Billion | €7.25 Billion | Finland | €67.35 | -1.25% | -2.04% | 5.46 Million |
| 35 |
Sichuan Kelun Pharmaceutical Co Ltd
SHE:002422 |
$8.36 Billion | CN¥57.14 Billion | China | CN¥35.92 | +0.84% | -3.08% | 477.41 Million |
| 36 |
ORION CORP.B UNSP.ADR 1/2
F:OFK0 |
$8.31 Billion | €7.10 Billion | Germany | €36.20 | -1.09% | -0.55% | 40.00 |
| 37 |
Grifols S.A.
MC:GRF |
$4.49 Billion | €3.84 Billion | Spain | €9.10 | +1.04% | +3.10% | 67.26 Million |
| 38 |
Grifols S.A
F:G0FB |
$4.42 Billion | €3.78 Billion | Germany | €6.25 | -2.34% | +0.00% | 693.00 |
| 39 |
GlaxoSmithKline Pharmaceuticals Limited
NSE:GLAXO |
$4.27 Billion | Rs395.05 Billion | India | Rs2332.00 | +2.90% | +10.88% | 3.47 Million |
| 40 |
GRIFOLS ADR 1/2/EO-50
F:G0F |
$4.21 Billion | €3.60 Billion | Germany | €4.26 | -2.74% | -1.84% | 192.00 |
| 41 |
Organon & Co
NYSE:OGN |
$3.52 Billion | $3.52 Billion | USA | $13.43 | +0.07% | +0.37% | 61.46 Million |
| 42 |
Virbac SA
PA:VIRP |
$3.01 Billion | €2.58 Billion | France | €340.50 | +3.34% | -0.58% | 82.10K |
| 43 |
AstraZeneca PLC
LSE:AZN |
$2.50 Billion | GBX20.52 Trillion | UK | GBX13234.00 | +0.61% | -2.53% | 47.90 Million |
| 44 |
Orion Oyj A
HE:ORNAV |
$2.48 Billion | €2.12 Billion | Finland | €66.60 | -2.49% | -2.92% | 125.21K |
| 45 |
Pfizer Limited
NSE:PFIZER |
$2.24 Billion | Rs207.41 Billion | India | Rs4533.70 | -0.12% | -0.86% | 690.00K |
| 46 |
Kalbe Farma Tbk PT
JK:KLBF |
$1.86 Billion | Rp31.72 Trillion | Indonesia | Rp700.00 | -1.41% | -0.71% | 2.08 Billion |
| 47 |
Aurora Optoelectronics Co Ltd
SHG:600666 |
$1.83 Billion | CN¥12.52 Billion | China | CN¥4.55 | -2.57% | +0.66% | 4.23 Billion |
| 48 |
Yifan Xinfu Pharmaceutical Co Ltd
SHE:002019 |
$1.73 Billion | CN¥11.81 Billion | China | CN¥9.71 | -1.02% | -3.67% | 217.39 Million |
| 49 |
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd
SHE:300357 |
$1.63 Billion | CN¥11.13 Billion | China | CN¥21.25 | +1.53% | -2.61% | 169.07 Million |
| 50 |
Cosmo Pharmaceuticals N.V
F:C43 |
$1.49 Billion | €1.27 Billion | Germany | €74.40 | -1.46% | -1.59% | 127.00 |
| 51 |
Zhejiang Jolly Pharmaceutical Co Ltd
SHE:300181 |
$1.32 Billion | CN¥9.00 Billion | China | CN¥12.83 | -1.61% | -4.18% | 201.68 Million |
| 52 |
COSMO Pharmaceuticals SA
SW:COPN |
$1.28 Billion | CHF1.01 Billion | Switzerland | CHF68.50 | +3.01% | -1.15% | 808.01K |
| 53 |
SANOFI CONS HEALTHC IND L
NSE:SANOFICONR |
$1.20 Billion | Rs110.83 Billion | India | Rs4812.50 | -2.75% | +4.58% | 290.95K |
| 54 |
GuangYuYuan Chinese Herbal Medicine Co Ltd
SHG:600771 |
$966.26 Million | CN¥6.60 Billion | China | CN¥13.49 | -1.10% | -3.44% | 148.13 Million |
| 55 |
NanJing Pharmaceutical Co Ltd
SHG:600713 |
$953.86 Million | CN¥6.52 Billion | China | CN¥4.98 | +0.20% | +0.20% | 214.99 Million |
| 56 |
GlaxoSmithKline PLC
LSE:GSK |
$941.03 Million | GBX7.73 Trillion | UK | GBX1925.50 | +0.13% | -1.89% | 126.33 Million |
| 57 |
Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd.
SHE:301096 |
$890.60 Million | CN¥6.09 Billion | China | CN¥55.72 | +1.05% | -1.55% | 87.96 Million |
| 58 |
Sanofi India Limited
NSE:SANOFI |
$832.13 Million | Rs76.95 Billion | India | Rs3341.00 | -0.88% | +6.22% | 673.13K |
| 59 |
Shandong Keyuan Pharmaceutical Co. Ltd. A
SHE:301281 |
$793.42 Million | CN¥5.42 Billion | China | CN¥50.07 | -0.22% | +11.22% | 107.06 Million |
| 60 |
Chongqing Lummy Pharmaceutical
SHE:300006 |
$760.20 Million | CN¥5.20 Billion | China | CN¥4.92 | -1.01% | -4.47% | 627.86 Million |
| 61 |
Hunan Jingfeng Pharmaceutical
SHE:000908 |
$750.55 Million | CN¥5.13 Billion | China | CN¥5.83 | -2.67% | -14.14% | 350.35 Million |
| 62 |
Zhejiang Int'L Group Co Ltd
SHE:000411 |
$732.38 Million | CN¥5.00 Billion | China | CN¥9.59 | -2.74% | +2.02% | 369.16 Million |
| 63 |
SENORES PHARMACEUTICALS L
NSE:SENORES |
$654.94 Million | Rs60.56 Billion | India | Rs1315.00 | -0.03% | +13.29% | 14.96 Million |
| 64 |
Hangzhou Minsheng Healthcare Co Ltd
SHE:301507 |
$638.10 Million | CN¥4.36 Billion | China | CN¥12.23 | +0.82% | +0.33% | 71.64 Million |
| 65 |
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A
SHG:600613 |
$331.76 Million | CN¥2.27 Billion | China | CN¥4.73 | -0.21% | -3.27% | 143.42 Million |
| 66 |
Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd
SHG:600671 |
$320.05 Million | CN¥2.19 Billion | China | CN¥17.96 | +9.98% | +10.46% | 49.37 Million |
| 67 |
Dimed S.A. Distribuidora de Medicamentos
SA:PNVL3 |
$318.14 Million | R$1.62 Billion | Brazil | R$10.88 | +1.68% | -4.90% | 23.47 Million |
| 68 |
Amarin Corporation PLC
NASDAQ:AMRN |
$315.59 Million | $315.59 Million | USA | $16.03 | +1.65% | +8.60% | 1.89 Million |
| 69 |
Zhejiang Zhenyuan Share Co Ltd
SHE:000705 |
$308.51 Million | CN¥2.11 Billion | China | CN¥6.31 | -1.10% | -6.52% | 141.66 Million |
| 70 |
Hubei Guangji Pharmaceutical Co Ltd
SHE:000952 |
$302.41 Million | CN¥2.07 Billion | China | CN¥5.96 | +0.00% | -2.93% | 149.34 Million |
| 71 |
Guangdong Jiaying Pharmaceutical Co Ltd
SHE:002198 |
$247.30 Million | CN¥1.69 Billion | China | CN¥3.33 | -3.20% | -8.26% | 322.84 Million |
| 72 |
NGL Fine-Chem Limited
NSE:NGLFINE |
$204.15 Million | Rs18.88 Billion | India | Rs3055.60 | +0.33% | +12.48% | 741.25K |
| 73 |
TTK Healthcare Limited
NSE:TTKHLTCARE |
$142.03 Million | Rs13.13 Billion | India | Rs929.40 | +5.21% | +4.44% | 75.36K |
| 74 |
Daishin Balance No.6 Special Purpose Acquisition Co. Ltd
KQ:307750 |
$78.38 Million | ₩115.66 Billion | Korea | ₩2305.00 | -3.56% | -5.53% | 5.95 Million |
| 75 |
Scilex Holding Company
NASDAQ:SCLX |
$48.60 Million | $48.60 Million | USA | $7.47 | +7.64% | -15.11% | 2.63 Million |
| 76 |
PharmGen Science Inc
KO:004720 |
$43.21 Million | ₩63.77 Billion | Korea | ₩2910.00 | -3.00% | -6.73% | 1.59 Million |
| 77 |
MIRA Pharmaceuticals, Inc. Common Stock
NASDAQ:MIRA |
$39.88 Million | $39.88 Million | USA | $0.95 | -2.64% | -2.84% | 2.99 Million |
| 78 |
Singbao International Co Ltd
TWO:6130 |
$36.51 Million | NT$1.16 Billion | Taiwan | NT$24.50 | +1.03% | +1.03% | 5.61 Million |
| 79 |
Nasus Pharma Ltd.
NYSE MKT:NSRX |
$33.96 Million | $33.96 Million | USA | $2.90 | +1.05% | -2.36% | 2.69 Million |
| 80 |
Yung Zip Chemical Ind Co Ltd
TWO:4102 |
$25.37 Million | NT$805.11 Million | Taiwan | NT$19.00 | +0.26% | +6.74% | 2.45 Million |
| 81 |
Korean Drug Co. Ltd
KQ:014570 |
$24.56 Million | ₩36.25 Billion | Korea | ₩3350.00 | -1.18% | +0.00% | 488.50K |
| 82 |
BCWORLD PHARM. Co. Ltd
KQ:200780 |
$23.35 Million | ₩34.45 Billion | Korea | ₩3370.00 | -1.46% | -6.39% | 442.72K |
| 83 |
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B
SHG:900904 |
$23.05 Million | $23.05 Million | China | $0.42 | -0.24% | -1.41% | 1.32 Million |
| 84 |
Lipidor Ab
ST:LIPI |
$18.82 Million | Skr174.88 Million | Sweden | Skr0.22 | +0.00% | +0.00% | 0.00 |
| 85 |
Medicus Pharma Ltd. Common Stock
NASDAQ:MDCX |
$18.41 Million | $18.41 Million | USA | $0.46 | +30.08% | +42.97% | 38.37 Million |
| 86 |
Chorokbaem Healthcare Co Ltd
KO:118000 |
$16.63 Million | ₩24.55 Billion | Korea | ₩1429.00 | -1.99% | -2.19% | 1.66 Million |
| 87 |
Firebrick Pharma Ltd
AU:FRE |
$7.45 Million | AU$10.54 Million | Australia | AU$0.04 | -7.50% | -5.13% | 10.83 Million |
Track real-time market capitalization of largest public companies in the Drug Manufacturers - General industry. Compare marketcap, analyze stock performance, and discover leading drug manufacturers - general corporations. View all industries